Consistent with the role of CD274 in the immune tolerance of healthy tissues, treatment with anti-PD-1/PD-L1 antibody for various malignancies results in serious side effects such as gastrointestinal toxicity, skin rashes, and alopecia [42], as well as kidney, liver, and lung injury [43]. This evidence concerns the gene PDCD1 and exanthem.